Alternative Graft Materials for Hemodialysis Access

Seminars in Vascular Surgery

Volumn 17, Issue 1, 2004, Pages 19-24

  Scher, Larry A ^a   Katzman, Howard E ^b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

POLITEF;

ARTERIOVENOUS FISTULA; AUTOGRAFT; FEMORAL VEIN; FOREARM; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTHESIS; REVIEW; SURGICAL PATIENT; VALIDATION PROCESS; VASCULAR ACCESS; VASCULAR PATENCY; VEIN;

EID: 1542636142     PISSN: 08957967     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semvascsurg.2003.11.007     Document Type: Article

References (34)

1. Arora P, Kausz AT, Obrador GT, et al: Hospital utilization among chronic dialysis patients. J Am Soc Nephrol 11:740-746, 2000
2. Clark PB, Parsons FM: Routine use of the Scribner shunt for hemodialysis. Br Med J 14:1200-1202, 1966
3. Brescia MJ, Cimino JE, Appel K, et al: Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 275:1089-1092, 1966
4. National Kidney Foundation: Kidney Disease Outcomes Quality Initiative (NKF K/DOQI) clinical practice guidelines for vascular access. Am J Kidney Dis 37((suppl 1)):s137-s181, 2001
5. Silva MB, Hobson RW, Pappas PJ, et al: Vein transposition in the forearm for autogenous hemodialysis access. J Vasc Surg 26:981-986, 1997
6. Rivers SP, Scher LA, Sheehan E, et al: Basilic vein transposition: An underutilized autologous alternative to prosthetic dialysis angioaccess. J Vasc Surg 18:391-396, 1993
7. Gradman WS, Cohen W, Haji-Aghaii M: Arteriovenous fistula construction in the thigh with transposed superficial femoral vein: Our initial experience. J Vasc Surg 33:968-975, 2001
8. Haimov M, Burrows L, Schanzer H, et al: Experience with arterial substitutes in the construction of vascular access for hemodialysis. J Cardiovasc Surg 21:149-154, 1980
9. Bone GE, Pomajzl MJ: Prospective comparison of polytetrafluoroethylene and bovine grafts for dialysis. J Surg Res 29:223-227, 1980
10. Garvin PJ, Castaneda MA, Codd JE: Etiology and management of bovine graft aneurysms. Arch Surg 117:281-284, 1982
11. Dardik H, Ibrahim IM, Dardik I: Arteriovenous fistulas constructed with modified human umbilical cord vein graft. Arch Surg 111:60-62, 1976
12. Hasson JE, Newton WD, Waltman AC, et al: Mural degeneration in the gluteraldehyde tanned umbilical vein graft: Incidence and implications. J Vasc Surg 4:243-250, 1986
13. Baker LD, Johnson JM, Goldfarb D: Expanded polytetrafluoroethylene (PTFE) subcutaneous arteriovenous conduit: An improved vascular access for chronic hemodialysis. Trans Am Soc Artif Intern Organs 22:382-387, 1976
14. Tellis VA, Kohlberg WI, Bhat DJ, et al: Expanded polytetrafluoroethylene graft fistula for chronic hemodialysis. Ann Surg 189:101-105, 1979
15. Miller PE, Carlton D, Deierhoi MH, et al: Natural history of arteriovenous grafts in hemodialysis patients. Am J Kidney Dis 36:68-74, 2000
16. Gibson KD, Gillen DL, Caps MT, et al: Vascular access survival and incidence of revision: A comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study. J Vasc Surg 34:694-7000, 2001
17. Schuman ES, Standage BA, Ragsdale JW, et al: Reinforced versus nonreinforced polytetrafluoroethylene grafts for hemodialysis access. Am J Surg 173:407-410, 1997
18. Lenz BJ, Veldenz HC, Dennis JW, et al: A three-year follow-up on standard versus thin wall ePTFE grafts for hemodialysis. J Vasc Surg 28:464-470, 1998
19. Tordoir JH, Hofstra L, Leunissen KM, et al: Early experience with stretch polytetrafluoroethylene grafts for hemodialysis access surgery: Results of a prospective randomised study. Eur J Vasc Endovasc Surg 9:305-309, 1995
20. Hiranaka T: Tapered and straight grafts for hemodialysis access: A prospective, randomized comparison study, in Henry ML (ed): Vascular Access for Hemodialysis VII. Chicago, IL, Precept Press, 2001, pp 219-224
21. Dammers R, Planken RN, Pouls KP, et al: Evaluation of 4-mm to 7-mm versus 6-mm prosthetic brachial-antecubital forearm loop access for hemodialysis: Results of a multicenter clinical trial. J Vasc Surg 37:143-148, 2003
22. Nyberg SL, Hughes CB, Valenzuela YM, et al: Preliminary experience with a cuffed ePTFE graft for hemodialysis vascular access. ASAIO J 47:333-3337, 2001
23. Sorom AJ, Hughes CB, McCarthy, et al: Prospective, randomized evaluation of a cuffed expanded polytetrafluoroethylene graft for hemodialysis vascular access. Surgery 132:135-140, 2002
24. Kaufman J, Garb JL, Berman JA, et al: A prospective comparison of two expanded polytetrafluoroethylene grafts for linear forearm hemodialysis: Does the manufacturer matter? J Am Coll Surg 185:74-79, 1997
25. Rosas SE, Joffe M, Burns JE, et al: Determinants of successful synthetic hemodialysis graft placement. J Vasc Surg 37:1036-1042, 2003
26. Comprehensive Hemodialysis Access PTFE Study (CHAPS Trial), unpublished data.
27. Glickman MH, Stokes GK, Ross JR, et al: Multicenter evaluation of a polyurethane vascular access graft as compared with the expanded polytetrafluoroethylene vascular access graft in hemodialysis applications. J Vasc Surg 34:465-472, 2001
28. Katzman HE, Lawson JH, Glickman MH: Development and maintenance of hemodialysis access in patients with prior failed synthetic grafts: Impact of mesenteric vein bioprosthetic graft. Presented at the Thirty-first Annual Symposium on Vascular Surgery of the Society for Clinical Vascular Surgery. Miami, FL, March 5-9, 2003
29. Glickman MH, Lawson JH, Katzman HE: Challenges of hemodialysis access for high-risk patients: Impact of mesenteric vein bioprosthesic graft. Presented at the Twenty-seventh Annual Meeting of the Southern Association for Vascular Surgery. Tucson AZ, January 15-18, 2003
30. Matsuura JH, Johansen KH, Rosenthal D, et al: Cryopreserved femoral vein grafts for difficult hemodialysis access. Ann Vasc Surg 14:50-55, 2000
31. Bolton WD, Cull DL, Taylor SM, et al: The use of cryopreserved femoral vein grafts for hemodialysis access in patients at high risk for infection: A word of caution. J Vasc Surg 36:464-468, 2002
32. Schwab SJ, Weiss MA, Rushton F, et al: Multicenter clinical trial results with the LifeSite hemodialysis access system. Kidney Int 62:1026-1033, 2002
33. Ryan SS, Chaikof EL, Terramani TT, et al: The LifeSite hemodialysis access system in patients with limited access. Presented at the Thirty-first Annual Symposium on Vascular Surgery of the Society for Clinical Vascular Surgery. Miami, FL, March 5-9, 2003
34. Lee H, Manns B, Taub K, et al: Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis 40:611-622, 2002